


Searching News Database: pandemic influenza
HSMN NewsFeed - 19 Mar 2020
BiondVax's CEO Comments on Impact of COVID-19 Pandemic on the Company's Ongoing Phase 3 Clinical Trial
BiondVax's CEO Comments on Impact of COVID-19 Pandemic on the Company's Ongoing Phase 3 Clinical Trial
HSMN NewsFeed - 14 Aug 2018
BiondVax Receives Second €6M Tranche Disbursement From the European Investment Bank (EIB)
BiondVax Receives Second €6M Tranche Disbursement From the European Investment Bank (EIB)
HSMN NewsFeed - 28 Jun 2018
Corporate Biotech Executive Mark Germain Joins BiondVax's Board of Directors
Corporate Biotech Executive Mark Germain Joins BiondVax's Board of Directors
HSMN NewsFeed - 19 Aug 2014
FDA Approves Use of AFLURIA(R) Influenza Vaccine with PharmaJet’s Needle-Free Injector
FDA Approves Use of AFLURIA(R) Influenza Vaccine with PharmaJet’s Needle-Free Injector
HSMN NewsFeed - 2 Dec 2013
Visterra Closes $8.1 Million Financing and Expands Executive Team to Accelerate Company Growth
Visterra Closes $8.1 Million Financing and Expands Executive Team to Accelerate Company Growth
HSMN NewsFeed - 15 Jul 2013
Visterra Appoints Brian Pereira, M.D., as President and Chief Executive Officer
Visterra Appoints Brian Pereira, M.D., as President and Chief Executive Officer
HSMN NewsFeed - 9 Nov 2012
Visterra Secures Financing From Gates Foundation and Omega to Close $26M Series A Financing
Visterra Secures Financing From Gates Foundation and Omega to Close $26M Series A Financing
HSMN NewsFeed - 2 Dec 2010
Baxter and Takeda Complete Agreement for Vero Cell-Based Influenza Vaccines in Japan
Baxter and Takeda Complete Agreement for Vero Cell-Based Influenza Vaccines in Japan
HSMN NewsFeed - 6 Jul 2010
Novavax Announces Appointment of Dr. Gregory Glenn as Chief Scientific Officer
Novavax Announces Appointment of Dr. Gregory Glenn as Chief Scientific Officer
HSMN NewsFeed - 27 Jan 2010
Juvaris BioTherapeutics Completes Second Close on $25 Million Series B Financing
Juvaris BioTherapeutics Completes Second Close on $25 Million Series B Financing
HSMN NewsFeed - 7 Oct 2009
Baxter Receives European Commission Approval for CELVAPAN H1N1 Pandemic Influenza Vaccine
Baxter Receives European Commission Approval for CELVAPAN H1N1 Pandemic Influenza Vaccine
HSMN NewsFeed - 17 Sep 2009
Juvaris BioTherapeutics Announces First Close on $25 million Series B Financing
Juvaris BioTherapeutics Announces First Close on $25 million Series B Financing
HSMN NewsFeed - 19 Feb 2008
Novavax Enters Into Estrasorb(R) Asset Sale and Supply Agreements with Graceway Pharmaceuticals, LLC
Novavax Enters Into Estrasorb(R) Asset Sale and Supply Agreements with Graceway Pharmaceuticals, LLC
HSMN NewsFeed - 13 Jun 2007
GlaxoSmithKline to Make Unprecedented Vaccine Donation to WHO Pandemic Flu Stockpile
GlaxoSmithKline to Make Unprecedented Vaccine Donation to WHO Pandemic Flu Stockpile
HSMN NewsFeed - 14 Mar 2007
Novavax Appoints James Robinson Vice President of Technical and Quality Operations
Novavax Appoints James Robinson Vice President of Technical and Quality Operations
HSMN NewsFeed - 25 Jan 2007
BioCryst Initiates Phase II Influenza Clinical Trial to Evaluate Peramivir
BioCryst Initiates Phase II Influenza Clinical Trial to Evaluate Peramivir
HSMN NewsFeed - 17 Jan 2007
GlaxoSmithKline Awarded $63 Million HHS Contract for Pandemic Vaccine Research and Development
GlaxoSmithKline Awarded $63 Million HHS Contract for Pandemic Vaccine Research and Development
HSMN NewsFeed - 20 Dec 2006
Sanofi pasteur Influenza Vaccine Production Tops 170 Million Doses in 2006
Sanofi pasteur Influenza Vaccine Production Tops 170 Million Doses in 2006
HSMN NewsFeed - 6 Nov 2006
VIASYS Healthcare to Supply New York State Ventilators for Emergency Preparedness
VIASYS Healthcare to Supply New York State Ventilators for Emergency Preparedness
HSMN NewsFeed - 5 Oct 2006
GSK's New Flu Vaccine, FluLaval(TM), Provides Americans With a New Option for Fighting the Flu
GSK's New Flu Vaccine, FluLaval(TM), Provides Americans With a New Option for Fighting the Flu
HSMN NewsFeed - 2 Oct 2006
PowderMed to Conduct U.S. Clinical Trial of DNA-Based Annual Influenza Vaccine
PowderMed to Conduct U.S. Clinical Trial of DNA-Based Annual Influenza Vaccine
HSMN NewsFeed - 20 Jul 2006
GSK Announces U.S. Government Purchase of Relenza(R) for State Stockpiles
GSK Announces U.S. Government Purchase of Relenza(R) for State Stockpiles
HSMN NewsFeed - 6 Jul 2006
MedImmune Receives FDA Approval to Use Reverse Genetics Technology for FluMist(R) Vaccine Production
MedImmune Receives FDA Approval to Use Reverse Genetics Technology for FluMist(R) Vaccine Production
Additional items found! 13
Members Archive contains
13 additional stories matching:
pandemic influenza
(Password required)
pandemic influenza
(Password required)
